Also published in ncbi.nlm.nih.gov:
Phase 1 evaluation of EZN-2208, a polyethylene glycol conjugate of SN38, in children adolescents and young adults with relapsed or refractory solid tumors.
x hide permanently

Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma.

ncbi.nlm.nih.gov

Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma.

J Natl Cancer Inst. 2017 Oct 01;109(10):

Authors: Hungate EA, Applebaum MA, Skol AD, Vaksman Z, Diamond M, McDaniel L, Volchenboum SL, Stranger BE, Maris JM, Diskin SJ, Onel K, Cohn SL

Mentions: MYCN